These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 34451903)

  • 1. Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus.
    Blahova J; Martiniakova M; Babikova M; Kovacova V; Mondockova V; Omelka R
    Pharmaceuticals (Basel); 2021 Aug; 14(8):. PubMed ID: 34451903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of multifunctional myricetin for treatment of type 2 diabetes mellitus.
    Niisato N; Marunaka Y
    Front Nutr; 2023; 10():1175660. PubMed ID: 37305094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Patents Issued in China for Antihyperglycemic Therapies for Type 2 Diabetes Mellitus.
    Zhu W; Huang W; Xu Z; Cao M; Hu Q; Pan C; Guo M; Wei JF; Yuan H
    Front Pharmacol; 2019; 10():586. PubMed ID: 31214029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of diabetes mellitus-imperative role of natural products against dipeptidyl peptidase-4, α-glucosidase and sodium-dependent glucose co-transporter 2 (SGLT2).
    Abbas G; Al Harrasi A; Hussain H; Hamaed A; Supuran CT
    Bioorg Chem; 2019 May; 86():305-315. PubMed ID: 30738330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Food Polyphenols and Type II Diabetes Mellitus: Pharmacology and Mechanisms.
    Naz R; Saqib F; Awadallah S; Wahid M; Latif MF; Iqbal I; Mubarak MS
    Molecules; 2023 May; 28(10):. PubMed ID: 37241737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug interactions of clinical importance with antihyperglycaemic agents: an update.
    Scheen AJ
    Drug Saf; 2005; 28(7):601-31. PubMed ID: 15963007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics, efficacy and safety of sodium-glucose co-transporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus.
    Scheen AJ
    Drugs; 2015 Jan; 75(1):33-59. PubMed ID: 25488697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of current therapeutic interventions on insulin resistance.
    Kobayashi M
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S32-40. PubMed ID: 11220286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of polyphenols in combating Type 2 Diabetes and insulin resistance.
    Shahwan M; Alhumaydhi F; Ashraf GM; Hasan PMZ; Shamsi A
    Int J Biol Macromol; 2022 May; 206():567-579. PubMed ID: 35247420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
    Hemmingsen B; Schroll JB; Lund SS; Wetterslev J; Gluud C; Vaag A; Sonne DP; Lundstrøm LH; Almdal T
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009008. PubMed ID: 23633364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Interactions of Clinical Importance with Antihyperglycaemic Agents : An Update.
    Scheen AJ
    Drug Saf; 2005 Jul; 28(7):601-631. PubMed ID: 27722966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
    Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments and emerging therapies for type 2 diabetes mellitus.
    Evans AJ; Krentz AJ
    Drugs R D; 1999 Aug; 2(2):75-94. PubMed ID: 10820647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus.
    Tahrani AA; Barnett AH; Bailey CJ
    Nat Rev Endocrinol; 2016 Oct; 12(10):566-92. PubMed ID: 27339889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and options for combination therapy in the treatment of Type 2 diabetes.
    Van Gaal LF; De Leeuw IH
    Diabetologia; 2003 Mar; 46 Suppl 1():M44-50. PubMed ID: 12652358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus: new challenges and innovative therapies.
    Sena CM; Bento CF; Pereira P; Seiça R
    EPMA J; 2010 Mar; 1(1):138-63. PubMed ID: 23199048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in understanding the anti-diabetic actions of dietary flavonoids.
    Babu PV; Liu D; Gilbert ER
    J Nutr Biochem; 2013 Nov; 24(11):1777-89. PubMed ID: 24029069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.